"Poliovirus Vaccine, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
| Descriptor ID |
D011055
|
| MeSH Number(s) |
D20.215.894.899.623.750
|
| Concept/Terms |
Poliovirus Vaccine, Oral- Poliovirus Vaccine, Oral
- Oral Poliovirus Vaccine
- Vaccine, Oral Poliovirus
- Sabin Vaccine
- Vaccine, Sabin
|
Below are MeSH descriptors whose meaning is more general than "Poliovirus Vaccine, Oral".
Below are MeSH descriptors whose meaning is more specific than "Poliovirus Vaccine, Oral".
This graph shows the total number of publications written about "Poliovirus Vaccine, Oral" by people in this website by year, and whether "Poliovirus Vaccine, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Poliovirus Vaccine, Oral" by people in Profiles.
-
One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19. Front Public Health. 2022; 10:967920.
-
Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol. 2004 Oct; 78(20):11097-107.
-
Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered. J Infect Dis. 2001 Nov 15; 184(10):1293-9.
-
Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine in the same syringe and inactivated polio vaccine. Pediatr Infect Dis J. 2000 Aug; 19(8):710-7.
-
Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants. Pediatr Infect Dis J. 1997 Sep; 16(9):863-70.
-
The effect of epidemic measles on immunization rates. JAMA. 1996 Jul 03; 276(1):56-8.
-
Polio vaccine and BGS. Neurology. 1990 Apr; 40(4):729.
-
Paralytic poliomyelitis in a child with hypogammaglobulinemia: probable implication of type I vaccine strain. Pediatrics. 1966 Apr; 37(4):630-6.